Search results
Chronic wasting disease: Death of 2 hunters in US raises fear of 'zombie deer'
USA Today· 5 days agoTwo hunters who ate meat from deer known to have chronic wasting disease − or "zombie deer disease"...
For immigrants to Canada, risk of multiple sclerosis increases with proportion of life spent there
Medical Xpress· 12 hours ago"Other studies have shown that immigrants tend to have better health than long-term residents, which...
Working routine job could boost risk of cognitive impairment, dementia: study
Deseret News via Yahoo News· 7 days agoThe more your work challenges your brain, the better it may be for your future brain health. That’s...
Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting...
Morningstar· 7 days agoNEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies ...
Acid reflux drugs could be causing migraines, US research suggests
dpa international via Yahoo News· 12 hours agoDealing with stomach acid reflux can sometimes be a headache, with advice often including lying on...
Novel Agent Curbs Alzheimer's-Related Agitation
Medscape· 2 days agoTreatment with AXS-05, a combination of dextromethorphan and bupropion, demonstrated rapid, sustained, and clinically meaningful improvement in agitation...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 hours agoIn April 2023 at the American Academy of Neurology Annual Meeting, neurosurgeon Dr. James Guest of the University ...
Novel Drug Made of Gold Nanocrystals Appears Safe in Multiple Sclerosis
MedPage Today· 3 days agoTreatment-emergent adverse events were transient and mostly mild to moderate, Barnett noted. Most...
Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple...
Morningstar· 6 days ago- Intranasal foralumab attenuated microglial activation in patients with non-active secondary progressive multiple sclerosis and progression independent of relapse (PIRA) -- Data presented in ...
Tiziana Life Sciences' foralumab study highlighted in Neurology Today
Proactive Investors· 6 days agoTiziana Life Sciences Ltd (NASDAQ:TLSA) said its study on foralumab, the company's lead candidate,...